192187-32-9Relevant articles and documents
Practical route to 2-quinolinones via a Pd-catalyzed C-H bond activation/C-C bond formation/cyclization cascade reaction
Wu, Junliang,Xiang, Shaohua,Zeng, Jing,Leow, Minli,Liu, Xue-Wei
supporting information, p. 222 - 225 (2015/01/30)
Quinolinone derivatives were constructed via a Pd-catalyzed C-H bond activation/C-C bond formation/cyclization cascade process with simple anilines as the substrates. This finding provides a practical procedure for the synthesis of quinolinone-containing alkaloids and drug molecules. The utility of this method was demonstrated by a formal synthesis of Tipifarnib.
Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors
Angibaud, Patrick,Bourdrez, Xavier,End, David W.,Freyne, Eddy,Janicot, Michel,Lezouret, Patricia,Ligny, Yannick,Mannens, Geert,Damsch, Siegrid,Mevellec, Laurence,Meyer, Christophe,Muller, Philippe,Pilatte, Isabelle,Poncelet, Virginie,Roux, Bruno,Smets, Gerda,Van Dun, Jacky,Van Remoortere, Pieter,Venet, Marc,Wouters, Walter
, p. 4365 - 4369 (2007/10/03)
A series of (4-chlorophenyl)-α-(1-methyl-1H-imidazol-5-yl) azoloquinolines and -quinazolines was prepared. These compounds displayed potent Farnesyl Protein Transferase inhibitory activity and tetrazolo[1,5-a] quinazolines are promising agents for oral in vivo inhibition.
Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives
-
, (2008/06/13)
PCT No. PCT/EP96/04515 Sec. 371 Date May 26, 1998 Sec. 102(e) Date May 26, 1998 PCT Filed Oct. 16, 1996 PCT Pub. No. WO97/21701 PCT Pub. Date Jun. 19, 1997This invention comprises the novel compounds of formula (I) wherein the dotted line represents an op